14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Novo Nordisk A/S stock price down 0.293% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 24, 2024 Loss -0.29% PDF

The Novo Nordisk A/S stock price fell by -0.293% on the last day (Thursday, 25th Apr 2024) from $126.16 to $125.79. During the last trading day the stock fluctuated 2.14% from a day low at $123.21 to a day high of $125.85. The price has fallen in 7 of the last 10 days but is still up by 0.31% over the past 2 weeks. Volume has increased on the last day by 307 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $425.53 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.00% during the next 3 months and, with a 90% probability hold a price between $130.61 and $155.18 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVO Signals & Forecast

There are mixed signals in the stock today. The Novo Nordisk A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $128.14. On a fall, the stock will find some support from the short-term average at $125.12. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -7.45%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Novo Nordisk A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $118.26 and $114.74. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $118.26. If this is broken, then the next support from accumulated volume will be at $114.74 and $109.02.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $2.64 between high and low, or 2.14%. For the last week the stock has had daily average volatility of 2.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVO) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Novo Nordisk A/S to open at $124.95, and during the day (based on 14 day Average True Range), to move between $123.05 and $128.53, which gives a possible trading interval of +/-$2.74 (+/-2.18%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 4.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $133.07 (5.79%) than the support at $118.26 (5.99%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Novo Nordisk A/S will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.770. We will update the financials statements for Novo Nordisk A/S, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 2.99% in the first trading day after earnings release.

Is Novo Nordisk A/S stock A Buy?

Novo Nordisk A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.938 Sell Candidate Unchanged

Predicted Opening Price for Novo Nordisk A/S of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$124.95 ( 0.668%) $125.79

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 127.59 1.43 %
R2 126.58 0.629 %
R1 125.96 0.134 %
Current price: 125.79
Support S1 123.94 -1.47 %
S2 123.32 -1.97 %
S3 122.31 -2.77 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 135.92 8.05 %
R2 133.49 6.12 %
R1 133.07 5.79 %
Current price 125.79
Support S1 118.26 -5.99%
S2 114.74 -8.78%
S3 109.02 -13.33%

NVO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 31, 2024 Mar 22, 2024 Apr 02, 2024 $0.93 0.735%
2 Aug 10, 2023 Aug 18, 2023 Aug 29, 2023 $0.88 0.93%
3 Feb 02, 2023 Mar 24, 2023 Apr 04, 2023 $1.19 1.50%
4 Aug 05, 2022 Aug 12, 2022 Aug 23, 2022 $0.584 1.10%
5 Mar 02, 2022 Mar 25, 2022 Apr 05, 2022 $1.04 1.80%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NVO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Novo Nordisk A/S Stock?
Novo Nordisk A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the Apr 25, 2024, the price of an Novo Nordisk A/S (NVO) share was $125.79.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $138.27 and the 52-week low is $75.56.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the Apr 25, 2024, the market capitalization of Novo Nordisk A/S is 562.237B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is May 02, 2024.
Click to get the best stock tips daily for free!

About Novo Nordisk A/S

Novo Nordisk A/S Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ... NVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT